Multi-omics analysis uncovers tumor ecosystem dynamics during neoadjuvant toripalimab plus nab-paclitaxel and S-1 for esophageal squamous cell carcinoma: a single-center, open-label, single-arm phase 2 trial.

EBioMedicine（2023）

引用 7|浏览16

暂无评分

摘要

This study was funded by Major projects of the ministry of science and technology of the 13th five-year plan of China [grant number: 2018ZX09201013].

查看译文

关键词

CD4 T cells,Esophageal squamous cell carcinoma,Neoadjuvant therapy,PD-L1,Serum proteins,TMB

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要